A2B5 Surface ganglioside binding distinguishes between two GFAP-positive clones from a human glioma-derived cell line

  • Knott J
  • Pilkington G
  • 1

    Readers

    Mendeley users who have this article in their library.
  • 8

    Citations

    Citations of this article.

Abstract

A human glioma-derived cell line which expresses both the astrocytic markers, glial fibrillary acidic protein (GFAP) and glutamine synthetase (GS) and cell surface gangliosides recognised by the A2B5 monoclonal antibody has been cloned. Two clones are described, which are A2B5-positive and A2B5-negative, respectively. These neoplastic clones may provide a suitable in vitro model with which to assess the significance of surface ganglioside expression in relation to function and lineage of mammalian glia. © 1990.

Author-supplied keywords

  • A2B5
  • GFAP
  • Glutamine synthetase
  • Human glioma
  • In vitro

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Johanna C A Knott

  • Geoffrey J. Pilkington

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free